Jeanette M. Kusel
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Methods for Evaluation of Surrogate Endpoints for Health Technology Assessment Decision Making: A Good Practices Report of an ISPOR Task Force.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: January 08, 2026
The impact of ultrasound-based antenatal screening strategies to detect vasa praevia in the United Kingdom: An exploratory study using decision analytic modelling methods.
Journal: PloS one
Published: August 18, 2021
The Impact of Price Reductions After Loss of Exclusivity in a Cost-Effectiveness Analysis: Fingolimod Versus Interferon Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis.
Journal: Journal of managed care & specialty pharmacy
Published: March 28, 2019
Costs and effectiveness of fingolimod versus alemtuzumab in the treatment of highly active relapsing-remitting multiple sclerosis in the UK: re-treatment, discount, and disutility.
Journal: Journal of medical economics
Published: June 22, 2017
Challenges Associated with Estimating Utility in Wet Age-Related Macular Degeneration: A Novel Regression Analysis to Capture the Bilateral Nature of the Disease.
Journal: Advances in therapy
Published: May 24, 2017
A discrete event simulation to model the cost-utility of fingolimod and natalizumab in rapidly evolving severe relapsing-remitting multiple sclerosis in the UK.
Journal: Journal of medical economics
Published: December 23, 2016
The Cost-Effectiveness of Ranibizumab Treat and Extend Regimen Versus Aflibercept in the UK.
Journal: Advances in therapy
Published: May 04, 2016
Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK.
Journal: Applied health economics and health policy
Published: May 01, 2016
The prevalence of child-specific utilities in NICE appraisals for paediatric indications: rise of the economic orphans?
Journal: Expert review of pharmacoeconomics & outcomes research
Published: April 16, 2016
Convergence yet Continued Complexity: A Systematic Review and Critique of Health Economic Models of Relapsing-Remitting Multiple Sclerosis in the United Kingdom.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: December 04, 2014
Impact Of Ethnicity On The Efficacy And Safety Outcomes Of Anti-Diabetes Drugs - Case Study Of Liraglutide In Asian And Non-Asian Populations.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Economic orphans? the prevalence of child-specific utilities in nice appraisals for paediatric indications.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Last Updated: 09/26/2026